BRAF and lung cancer: Given the fact that the epidemiology and clinical behaviors of lung cancer is different between East Asians and Caucasians [20], we examined the BRAF V600E mutation and HER2 exon 20 insertions in Chinese lung ADC patients in order to determine the frequency of these two mutations and identify their clinicopathological characteristics.